Publication | Closed Access

Population pharmacokinetic and covariate analysis of pertuzumab, a HER2-targeted monoclonal antibody, and evaluation of a fixed, non-weight-based dose in patients with a variety of solid tumors

Her2-targeted Monoclonal AntibodySolid TumorsMedicineImmunologyPathologyImmune Checkpoint InhibitorPharmacotherapyCancer TreatmentOncologyRadiation OncologyCancer ResearchCovariate Analysis